Myelofibrosis Latest Advances

Find the Latest Research About Myelofibrosis

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8799 publications

Myeloproliferative neoplasms in the young: unique disease patterns and therapeutic strategies.

Myeloproliferative neoplasms in the young: unique disease patterns and therapeutic strategies.

Journal: Current opinion in hematology
Published: January 20, 2026

Pharmacy and transfusion costs of ruxolitinib and momelotinib in patients with myelofibrosis and anemia.

Pharmacy and transfusion costs of ruxolitinib and momelotinib in patients with myelofibrosis and anemia.

Journal: Leukemia & lymphoma
Published: January 05, 2026

Rare Dual Genetic Diagnosis of Wiskott-Aldrich Syndrome and Ghoshal Hematodiaphyseal Dysplasia: Clinical, Diagnostic, and Management Challenges.

Rare Dual Genetic Diagnosis of Wiskott-Aldrich Syndrome and Ghoshal Hematodiaphyseal Dysplasia: Clinical, Diagnostic, and Management Challenges.

Journal: Cureus
Published: December 18, 2025

Pediatric Essential Thrombocythemia: A Case of a JAK2-Mutated Adolescent With Microvascular Symptoms.

Pediatric Essential Thrombocythemia: A Case of a JAK2-Mutated Adolescent With Microvascular Symptoms.

Journal: Cureus
Published: December 16, 2025

Risk and Outcomes of Second Malignancies in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasm: A SEER Database Analysis.

Risk and Outcomes of Second Malignancies in Patients With Philadelphia Chromosome-Negative Myeloproliferative Neoplasm: A SEER Database Analysis.

Journal: JCO oncology practice
Published: December 15, 2025

Current treatments, practical management, and emerging investigational therapies for myelofibrosis.

Current treatments, practical management, and emerging investigational therapies for myelofibrosis.

Journal: Expert review of hematology
Published: December 14, 2025

Interferon alpha in myeloproliferative neoplasms: evidence and practical considerations for clinical care.

Interferon alpha in myeloproliferative neoplasms: evidence and practical considerations for clinical care.

Journal: Leukemia & lymphoma
Published: December 08, 2025

Gupta V, Tomuleasa C, Barranco Lampón GI, et al. Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study. Blood Adv. 2025;9(5):1105-1116.

Gupta V, Tomuleasa C, Barranco Lampón GI, et al. Real-world treatment patterns and health care resource use for patients with myelofibrosis: results from the METER study. Blood Adv. 2025;9(5):1105-1116.

Journal: Blood advances
Published: November 25, 2025

Loss of Ezh2 precipitates lethal disease progression in a mouse model of Calr-mutated myeloproliferative neoplasms.

Loss of Ezh2 precipitates lethal disease progression in a mouse model of Calr-mutated myeloproliferative neoplasms.

Journal: Experimental hematology
Published: November 25, 2025

Synergistic effects of deleting the tyrosine phosphatases Shp1 and Shp2 on megakaryopoiesis and thrombopoiesis in mice.

Synergistic effects of deleting the tyrosine phosphatases Shp1 and Shp2 on megakaryopoiesis and thrombopoiesis in mice.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Splenic Artery Aneurysm Associated with Myelofibrosis Managed by Coil Embolization.

Splenic Artery Aneurysm Associated with Myelofibrosis Managed by Coil Embolization.

Journal: Internal medicine (Tokyo, Japan)
Published: November 19, 2025

Thoracoscopic Wedge Resection of Pulmonary Carcinoma with Myelofibrosis while Managing Thrombocytopenia:Report of a Case

Thoracoscopic Wedge Resection of Pulmonary Carcinoma with Myelofibrosis while Managing Thrombocytopenia:Report of a Case

Journal: Kyobu geka. The Japanese journal of thoracic surgery
Published: November 18, 2025
Showing 1-12 of 8,799

Last Updated: 02/24/2026